Search

everythinglearnresearchcommunity

for

Search:↓

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

PRP is an effective and safe treatment for alopecia areata.

A new rat strain with a specific gene mutation causes hair loss and kidney issues.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Topical tofacitinib is effective and safe for treating alopecia areata.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Cyclosporine A can help some people with severe alopecia areata regrow hair.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.